Celldex Therapeutics, Inc. of HAMPTON, NJ filed a DEF 14A with the SEC on 2018-04-30. Industry: In Vitro & In Vivo Diagnostic Substances.
| Seq | Type | Description |
|---|---|---|
| 1 | DEF 14A | DEF 14A |
| 2 | GRAPHIC | G29172BII001.GIF |
| 3 | GRAPHIC | G29172BII002.GIF |
Showing 12 of 49 filings.
| Filed | Form |
|---|---|
| 2026-04-29 | DEF 14A |
| 2025-04-21 | DEF 14A |
| 2024-04-25 | DEF 14A |
| 2023-04-25 | DEF 14A |
| 2022-04-26 | DEF 14A |
| 2021-04-27 | DEF 14A |
| 2020-04-28 | DEF 14A |
| 2019-05-07 | DEFA14A |
| 2019-04-26 | DEF 14A |
| 2018-04-30 | DEF 14A |
| 2018-04-19 | PRE 14A |
| 2017-04-28 | DEF 14A |